Non-Alcoholic Steatohepatitis (NASH) Survey

Non-Alcoholic Steatohepatitis (NASH) Survey

  • March 2017 •
  • 8 pages •
  • Report ID: 4885549 •
  • Format: PDF
Datamonitor conducted a 4-question survey of 42 United States and 40 European (based in France, Germany, Italy and United Kingdom) gastroenterologists to gauge their views on late-stage clinical candidates in non-alcoholic steatohepatitis (NASH), including Ocaliva (ICPT), elafibranor (GNFTF) and selonsertib (GILD), and their projected use of these drugs if FDA-approved.